Evidence map›Paper›PMID 29092944›Full record

ArticleCancer research2017

Platform for Quantitative Evaluation of Spatial Intratumoral Heterogeneity in Multiplexed Fluorescence Images.

Daniel M Spagnolo, Yousef Al-Kofahi, Peihong Zhu, Timothy R Lezon, Albert Gough, Andrew M Stern, Adrian V Lee, Fiona Ginty, Brion Sarachan, D Lansing Taylor and 1 more

Abstract read
In one paragraph

Article in Cancer research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Targeting NADMolecular cancer research : MCR · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Daniel M SpagnoloProgram in Computational Biology, Joint Carnegie Mellon University-University of Pittsburgh, Pittsburgh, Pennsylvania.
Yousef Al-KofahiSoftware Science and Analytics Organization, GE Global Research Center, Niskayuna, New York.
Peihong ZhuSoftware Science and Analytics Organization, GE Global Research Center, Niskayuna, New York.
Timothy R LezonDepartment of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Albert GoughDepartment of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Andrew M SternDepartment of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Adrian V LeeUniversity of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
Fiona GintyBiosciences Organization, GE Global Research Center, Niskayuna, New York.
Brion SarachanSoftware Science and Analytics Organization, GE Global Research Center, Niskayuna, New York.
D Lansing TaylorDepartment of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania.
S Chakra ChennubhotlaDepartment of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania. chakracs@pitt.edu.

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
TrainingU54HG008540 · NHGRI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BAHAR, IVET, BERG, JEREMY M · 2014 to 2018
$12.8M
Integrated Interdisciplinary, inter-university PhD Program Computational Biology (T32)T32EB009403 · NIBIB · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BAHAR, IVET, BAR-JOSEPH, ZIV · 2009 to 2023
$4.4M
Informatics Tools for Tumor Heterogeneity in Multiplexed Fluorescence ImagesU01CA204826 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SARACHAN, BRION DARYL, TAYLOR, D. LANSING · 2016 to 2018
$1.1M
Chemical biology of superstolides--a novel class of anticancer natural productsR21CA204836 · NCI · UNIVERSITY OF IOWA · PI JIN, ZHENDONG, LIU, JUN O. · 2016 to 2017
$373k
NCI NIH HHS P30 CA047904NCI NIH HHS R21 CA204836NCI NIH HHS U01 CA204826NHGRI NIH HHS U54 HG008540NIBIB NIH HHS T32 EB009403
6 · The paper itself

Abstract

We introduce THRIVE (Tumor Heterogeneity Research Interactive Visualization Environment), an open-source tool developed to assist cancer researchers in interactive hypothesis testing. The focus of this tool is to quantify spatial intratumoral heterogeneity (ITH), and the interactions between different cell phenotypes and noncellular constituents. Specifically, we foresee applications in phenotyping cells within tumor microenvironments, recognizing tumor boundaries, identifying degrees of immune infiltration and epithelial/stromal separation, and identification of heterotypic signaling networks underlying microdomains. The THRIVE platform provides an integrated workflow for analyzing whole-slide immunofluorescence images and tissue microarrays, including algorithms for segmentation, quantification, and heterogeneity analysis. THRIVE promotes flexible deployment, a maintainable code base using open-source libraries, and an extensible framework for customizing algorithms with ease. THRIVE was designed with highly multiplexed immunofluorescence images in mind, and, by providing a platform to efficiently analyze high-dimensional immunofluorescence signals, we hope to advance these data toward mainstream adoption in cancer research.

Indexed as

Genetic HeterogeneitySoftwareAlgorithmsHumansImage Processing, Computer-AssistedNeoplasmsOptical ImagingTissue Array Analysis

Identifiers

PMID29092944
PMCPMC5683175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.